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ABSTRACT: The HIV-1 ribosomal frameshift element is
highly structured, regulates translation of all virally encoded
enzymes, and is a promising therapeutic target. The prior
model for this motif contains two helices separated by a threenucleotide bulge. Modiﬁcations to this model were suggested
by SHAPE chemical probing of an entire HIV-1 RNA genome.
Novel features of the SHAPE-directed model include alternate
helical conformations and a larger, more complex structure.
These structural elements also support the presence of a
secondary frameshift site within the frameshift domain. Here,
we use oligonucleotide-directed structure perturbation, probing in the presence of formamide, and in-virion experiments to
examine these models. Our data support a model in which the frameshift domain is anchored by a stable helix outside the
conventional domain. Less stable helices within the domain can switch from the SHAPE-predicted to the two-helix conformation.
Translational frameshifting assays with frameshift domain mutants support a functional role for the interactions predicted by and
speciﬁc to the SHAPE-directed model. These results reveal that the HIV-1 frameshift domain is a complex, dynamic structure
and underscore the importance of analyzing folding in the context of full-length RNAs.

H

additional sequence and structures including pseudoknots,7−9 a
triple-stranded RNA species,10 and two helices.11 NMR studies
performed on 41- and 45-nucleotide (nt) transcripts support
the formation of the two-helix model.12,13 This conventional
two-helix model includes the originally proposed stem (now
termed the upper stem) and a lower stem that is separated from
the upper stem by a three-purine bulge (Figure 1). The
functional importance of this lower stem is supported by
experiments demonstrating decreased frameshifting when the
lower stem is destabilized by mutation11 or when a truncated
construct containing only the upper stem is used.14
An alternative, more complex model was proposed based on
SHAPE chemical probing experiments performed on an entire
HIV-1 genome.15 SHAPE probing yields a model-free measurement of local nucleotide ﬂexibility that, in turn, provides
nucleotide-resolution information about RNA secondary and
tertiary structure.16 SHAPE reactivities can be incorporated
into thermodynamics-based folding algorithms17 resulting in
highly accurate RNA secondary structure models.18,19 The
SHAPE-directed model of the frameshift domain includes ﬁve
helices (Figure 1). One is equivalent to the upper stem of the

IV-1 viral enzymes, including protease, reverse transcriptase, and integrase, are generated by cleavage of the
precursor polyprotein Gag-Pol. Although the Gag and Pol
polyproteins are translated together, the pol gene is encoded in
a reading frame oﬀset from the upstream gag reading frame by
one nucleotide in the 5′ direction. Consequently, translation of
the Gag-Pol fusion protein relies on programmed ribosomal
frameshifting that involves translation of the Gag polyprotein
followed by a recoding event that shifts the ribosome from the
gag to the pol reading frame.1 Frameshifting requires two key
elements: The ﬁrst is a highly conserved UUUUUUA sequence,
termed the slippery sequence, at which the switch in reading
frame occurs,2 and the second is a downstream structural
element termed the frameshift stimulatory stem. This downstream structure is thought to pause the ribosome while the A
and P sites are occupied by the slippery sequence. Although the
precise mechanism is not fully understood, frameshifting occurs
with a frequency of 5−10% in cultured HIV-transfected human
cells, and the Gag to Gag-Pol ratio appears to be important for
viral ﬁtness.3 The frameshifting process has consequently
attracted interest as a target for the development of therapeutic
agents.4,5
The original model for the downstream structural element
was a single stem-loop.6 A number of reﬁnements and
extensions of this model have been proposed that include
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pNL4-3 (obtained through the NIH AIDS Reagent Program,
Division of AIDS, NIAID, NIH: pNL4-3 from Dr. Malcolm
Martin24) was used to infect cells from a non-Hodgkin’s T cell
lymphoma line (SupT1-CCR5).25 Puriﬁed HIV-1 preparations
(1000× concentrates) were stored frozen at −80 °C until used.
In Virio RNA Modiﬁcation and Extraction of RNA
Genomes from Virions. Virions were treated as described,26
with the exception that the 1M7 SHAPE reagent was used in
place of NMIA. Brieﬂy, virions treated with 1M7 or unmodiﬁed
virions were digested with subtilisin and centrifuged through a
20% (w/v) sucrose cushion prior to the extraction of
genomes.27 Virions were then lysed by incubation in virion
lysis buﬀer [50 mM Tris (pH 7.5), 10 mM EDTA, 1% SDS,
100 mM NaCl, 10 mM DTT, 15 μL 20 mg/mL proteinase K]
(using 100 μL lysing buﬀer per 1 mL volume of 1000× HIV-1
culture supernatant concentrate) for 30 min at room
temperature. The digest was extracted four times with
phenol/chloroform/isoamyl alcohol, followed by four extractions with pure chloroform. The aqueous layer was brought to a
NaCl concentration of 300 mM, nucleic acids were precipitated
with 70% ethanol, and samples were stored at −20 °C. Pelleted
RNA was resuspended in storage buﬀer (50 mM HEPES, pH
8) at a ﬁnal RNA concentration of 400 nM. These aliquots
were ﬂash frozen in liquid N2 and stored at −80 °C.
Folding of Ex Virio RNA. For each reaction, 1 μL of 400
nM ex virio RNA (prepared as described above, without in virio
RNA chemical modiﬁcation) was dissolved in a Mg2+containing standard folding buﬀer [50 mM HEPES (pH 8),
200 mM potassium acetate (pH 8), and 3 mM MgCl2] to
promote the formation of native-like interactions (total volume
was 20 μL). This mixture was incubated at 37 °C for 30 min
before SHAPE modiﬁcation.
Formamide Denaturation. For the formamide denaturation experiments, 1 μL of 400 nM ex virio RNA was
resuspended in 5 μL of folding buﬀer and incubated at 37 °C
for 20 min. A formamide-containing folding buﬀer [67% (v/v)
deionized formamide, 50 mM HEPES (pH 8), 200 mM
potassium acetate (pH 8), and 3 mM MgCl2] was then
combined with the appropriate amount of standard folding
buﬀer and added to the reaction mix to obtain the desired
formamide concentration in a reaction volume of 20 μL.
Experiments were performed at ﬁnal formamide concentrations
of 0% to 60%, in increments of 10%. The RNA was incubated
in formamide for 20 min at 37 °C prior to SHAPE
modiﬁcation.
LNA Oligonucleotide Design. We used 9- and 10-nt LNA
oligonucleotides (Exiqon) that were the reverse complements
of HIV-1 sequences comprising helices proposed in the
SHAPE-directed frameshift model. The sequences were chosen
to avoid self-complementarity and to avoid stretches of three or
more G or C nucleotides. When possible, we included ﬂanking
single-stranded regions as part of the targeted strand to
facilitate LNA binding to structured helices. LNA oligonucleotide binding positions (in parentheses) refer to the NL4-3
genome (based on GenBank accession number AF324493,
starting at the beginning of the 5′ R-region, nucleotide 455),
and the sequences are 1 (1604−1612), CAATCTTTC; 2
(1629−1638), CTAAAAAATT; 3 (1588−1596),
GTCCTTCCT; 4 (1678−1686), TCTGAAGAA; 5 (1570−
1578), TCCAACAGC; and 6 (1697−1705), GCTGTTGGC.
LNA nucleotides are underlined; all others are DNA. Their
corresponding binding sites are shown in Figure 1.

Figure 1. Conventional11 and SHAPE-directed15 models of the
frameshift RNA element. Nucleotides are colored by SHAPE reactivity
(see key) of the ex virio RNA and are numbered relative to the NL4-3
genome.

two-helix model. One of the additional helices involves
refolding of the lower stem of the conventional model into a
helix we term the alternate lower stem. SHAPE data also
support the formation of three helices outside the domain
traditionally identiﬁed as the frameshift stimulatory element.
These include a helix that sequesters most of the slippery
sequence in base-pairing interactions and a 10-bp anchoring
helix. Finally, low SHAPE reactivity at a 3-nt strand between
the alternate lower stem and anchoring helix supports an
additional short secondary structure, which we currently model
as a 3-bp helix. SHAPE data suggest that the frameshift domain
spans 140 nts, a signiﬁcantly larger region than is included in
the two-helix model (Figure 1).
We used several strategies to explore the relative roles of
helices in the SHAPE-directed and two-helix models. We used
oligonucleotides containing locked nucleic acid (LNA)
residues20,21 to selectively disrupt predicted helices. We also
used SHAPE to monitor frameshift element structure in the
presence of formamide denaturant and in the context of the
RNA packaged inside virion particles. To assess the functional
importance of the frameshift domain helices, we used sitedirected mutagenesis to destabilize individual helices and
measured the resulting frameshift eﬃciency.22 Our results
provide strong support for the SHAPE-directed frameshift
model, and the functional importance of SHAPE-detected
conformations for frameshifting reveals that the frameshift
domain is a dynamic element capable of structural remodeling
and supports the existence of a secondary frameshift site. These
results were critically dependent on the use of the entire HIV-1
sequence, a fact that emphasizes the importance of sequence
context for studying large, complex functional domains in RNA.

■

METHODS
HIV-1 Virion Production. HIV-1 virion particles were
prepared as described.23 Brieﬂy, HIV-1 NL4-3 (group M,
subtype B) derived by the transfection of 293T cells with
4283
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reporter genes.22 Plasmid DNA was puriﬁed from cell cultures
(Qiagen), and the sequences of all constructs were veriﬁed by
sequencing.
RNA Synthesis, Puriﬁcation, and the Frameshift
Assay. RNAs for the frameshift assay were transcribed in
vitro from p2luc plasmid DNA linearized with PmlI, puriﬁed
His6-tagged T7 RNA polymerase (10×), 11.25 mM NTPs, and
2 units of RNase inhibitor (RNasin Plus; Promega, N2615) in
200 μL for 2 h at 37 °C. Pyrophosphate was pelleted by
centrifugation (10 min, 13,200 rpm), and RNA was extracted
with phenol/chloroform. Unincorporated NTPs and salt were
separated from the RNA by gel ﬁltration (Ilustra MicroSpin G25 Columns; GE Healthcare). RNAs were heated at 95 °C for 5
min followed by incubation on ice for 30 min. Samples were
lyophilized to dryness and resuspended in water at 1 μg/μL.
RNA integrity and purity were conﬁrmed with 1% agarose gel
electrophoresis.
In vitro frameshift assays were completed with each RNA
reporter using a rabbit reticulocyte lysate (RRL System;
Promega, nuclease treated, L416A). Translation reactions
contained 0.63 μg of RNA, 10 units of RNase inhibitor, and
8.8 μL of RRL in 12.5 μL. Following a 90 min incubation at 37
°C, reactions were quenched by the addition of EDTA (pH
8.0) to a ﬁnal concentration of 6 mM. For each reporter, a
minimum of three independent frameshift assays were
completed using diﬀerent preparations of mRNA (full biological replicates). Independent biological replicate assays
included four replicate reactions. Luminescence was measured
using the dual-luciferase reporter assay (Promega). Readings
were taken with a microplate luminometer (Veritas) equipped
with dual-injectors (Turner Biosystems) for 10 s after 25 μL of
the respective substrate was injected into the reaction mixture
(2 s lag time prior to measurement). Each experiment included
an in-frame positive control22 with a mutated “non-slippery
sequence” and an additional nucleotide inserted immediately
before the Sac I site, which places the rluc and ﬂuc genes inframe. Frameshift eﬃciencies were calculated by taking the ratio
of the experimental to control luminescence (ﬁreﬂy to Renilla).
Small variations in the activities of control reactions were
observed with diﬀerent preparations of mRNA and reticulocyte
lysates. To account for these diﬀerences, frameshift eﬃciencies
were normalized relative to wild-type levels, and averaged. The
non-normalized frameshift eﬃciencies for the native sequence
construct in all biological replicates (n = 9) was 5.4 ± 0.9%.
Standard deviations were propagated to yield a standard error
of the mean (SEM).

LNA Binding to Genomic RNA. For each LNA binding
experiment, 1 μL of 400 nM extracted HIV-1 genomic RNA in
storage buﬀer [50 mM HEPES (pH 8) and 200 mM potassium
acetate], 2 μL of 2 μM LNA, 4.6 μL of TE, and 1.7 μL of water
were mixed and heated at 95 °C for 5 min and then snap
cooled on ice. A 9.5 μL aliquot of 2× storage buﬀer and 1.2 μL
of 50 mM MgCl2 (20 μL total in folding buﬀer conditions)
were added and the solution incubated for 30 min at 37 °C
before the SHAPE modiﬁcation step.
SHAPE Modiﬁcation of Ex Virio, LNA-Bound, and
Formamide-Denatured RNA. SHAPE modiﬁcation was
performed by adding 9 μL each of RNA sample to 1 μL of
40 mM SHAPE reagent (1M7 for standard SHAPE reactions
and 1M6 and NMIA for diﬀerential SHAPE reactions) or 1 μL
of neat DMSO as a no-reagent control. The samples were
incubated for 4 min at 37 °C. We then added 1 μL of 50 mM
EDTA and performed a cleanup step to remove LNA
oligonucleotides if necessary (RNeasy Mini Kit; Qiagen). The
resulting mixture (100 μL) was precipitated with 10 μL of 2 M
NaCl and 300 μL of ethanol and stored at −80 °C until primer
extension.
Primer Extension and Capillary Electrophoresis
Detection of SHAPE Adduct Sites. Pellets containing
SHAPE-modiﬁed or control RNA were resuspended in 7 μL
of 0.5× TE and 6 μL of 0.4 μM VIC-labeled DNA primer
(Applied Biosciences). Primer extension reactions for LNA
binding experiments were performed using DNA primers
complementary to RNA genome nucleotide positions (see
above) 1750−1771 (primer 6.2, with sequence ATC GGC
TCC TGC TTC TGA GAG G) and 2033−2054 (primer 7,
with sequence CAA TTA TGT TGA CAG GTG TAG G). We
used primer 6.2 for formamide denaturation experiments and
primer 7 for in virio experiments. Primer extension reactions
were performed as described.28,29
Data Processing. Raw capillary electropherograms were
processed using QuShape.28 Brieﬂy, key processing steps
include a mobility shift to correct for small diﬀerences in the
electrophoretic mobility between the NED and VIC ﬂuorescent
dyes and a signal decay correction to account for signal
attenuation as the distance from the reverse transcriptase
primer binding site increases. DMSO control peaks were
subtracted from reagent peaks, and the resulting SHAPE
reactivities were normalized on a scale where a normalized
reactivity of 1.0 was deﬁned as the average intensity of the top
10% most reactive peaks, excluding a few highly reactive
nucleotides taken to be outliers. The resulting reactivities span
a scale from 0 to ∼1.5, where 0 indicates no reactivity (and a
highly constrained nucleotide) and reactivities >0.7 typically
indicate highly ﬂexible nucleotides.
Secondary Structure Modeling. SHAPE-directed models
for the frameshift domain were created by incorporating
SHAPE data into the RNAstructure folding algorithm.17,18 For
HIV, we used values of m = 3.0 kcal/mol and b = −0.6 kcal/
mol. To account for LNA binding, the LNA target site was
forced to be single stranded by imposing artiﬁcial SHAPE
reactivity values of 100. For LNA 5 and 6, which target the
highly stable anchoring helix, base pairing was also prohibited at
partner nucleotides as the observed reactivity increases were
taken to imply a single stranded state.
Plasmid Construction. Complementary synthetic oligonucleotides (IDT) with BamH I and Sac I compatible ends were
phosphorylated, annealed, and ligated into the p2luc vector
using the BamH I and Sac I sites between the rluc and ﬂuc

■

RESULTS
LNA Binding Supports the SHAPE-Directed Model of
the Frameshift Region. We initially attempted to bind
antisense LNAs to folded full-length genomic RNA extracted
from HIV-1 virions. However, addition of LNAs directed
against the anchoring helix failed to produce detectable SHAPE
reactivity changes in the predicted partner strand. This result
could reﬂect either that the targeted helix was too stable to be
disrupted by LNA binding or that our model in the frameshift
region was inaccurate. When we heated the HIV-1 RNA at 95
°C for 5 min in the presence of LNA and snap cooled on ice
prior to incubation in folding buﬀer, we found that SHAPE
reactivities did increase in the predicted partner strand upon
addition of LNA, indicative of a very stable target helix.
For the results obtained upon heat denaturation and LNA
binding in the frameshift element region to provide clear
4284
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Figure 2. SHAPE reactivities and predicted secondary structures for HIV-1 RNA bound to LNAs targeting the slippery sequence helix (A,B), the
SHAPE-supported alternate lower stem (C,D), and the anchoring helix (E,F).

probing reagents, 1M6 and NMIA, were used in these analyses.
1M6 and NMIA are sensitive to diﬀerent local structural states
and time scales and consequently provide a detailed structural
ﬁngerprint for an RNA.31,32 SHAPE reactivities for the genome
region near the frameshift element were highly similar in both

biological insights, the conformation adopted after heat
denaturation must be native-like. We performed SHAPE on
HIV-1 RNA gently extracted from virions and on a sample of
this same RNA following heat denaturation and refolding. The
standard SHAPE reagent 1M730 and two additional SHAPE
4285
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ex virio and in heated-refolded RNAs for all three reagents (r =
0.94−0.96, Supporting Information, Figure 1). We conclude
that the refolded frameshift domain adopts essentially the same
conformation as the ex virio HIV-1 RNA puriﬁed under
nondenaturing conditions.
We designed 9- and 10-nt LNA oligonucleotides to bind to
each of the strands of the three major helices unique to the
SHAPE-directed frameshift model (Figure 1). If the targeted
helix existed and if LNA binding disrupted native base pairing,
we expected to observe increased SHAPE reactivity at the
strand complementary to the LNA-bound strand. In all six
cases, SHAPE reactivity increased for at least some nucleotides
in the predicted partner strand (Figure 2, gray boxes). These
results strongly support the formation of the slippery sequence
(Figure 2A,B) and alternate lower (Figure 2C,D) and
anchoring helices (Figure 2E,F) in the full-length HIV-1 RNA.
LNA Binding Allows the Conventional Lower Stem to
Form. Although reactivity increases were consistently observed
at the predicted partner strand upon LNA binding, most LNAs
also induced additional SHAPE reactivity changes. For example,
LNA 1 was designed to disrupt the slippery sequence helix. In
addition to the expected increases in SHAPE reactivity at the
partner strand (Figure 2A, gray boxes), LNA 1 binding also
induced SHAPE reactivity increases at nucleotides 1585−1590
and decreases at nucleotides 1641−1644. Nucleotides 1585−
1590 are predicted to be single stranded in the SHAPE-directed
frameshift model, while nucleotides 1641−1644 are predicted
to form part of the alternate lower stem. The changes in
SHAPE reactivity upon LNA binding suggest the formation of
base-pairing interactions that correspond to the lower stem
from the conventional two-helix model (Figure 2A, red boxes).
Binding to the complementary side of the helix by LNA 2 did
not result in this conformational switch (Figure 2B). LNA 2
targets nucleotides in close proximity to, and possibly
overlapping with, the conventional lower stem. In this case,
steric occlusion due to LNA 2 binding likely disfavors
formation of the conventional lower stem.
LNA 3 was designed to disrupt the alternate lower stem.
LNA 3 induced relatively minor increases in reactivity in the
partner strand (Figure 2C, gray box) and more pronounced
changes in reactivity in other regions (Figure 2C, red and
yellow boxes). For example, reactivity at nucleotides 1641−
1643 was reduced relative to the reactivity in the no-LNA
control, consistent with the formation of the conventional
lower stem. LNA 4 was also designed to disrupt the alternate
lower stem, and its binding resulted in the expected reactivity
increases at the predicted partner strand but no signiﬁcant
changes elsewhere. We attribute this lack of a conformational
switch to the fact that LNA 4 binding would prevent the
formation of both the alternate and conventional conformations of the lower stem.
Binding by LNA 5 or LNA 6 also resulted in SHAPE
reactivity increases in the corresponding partner strands
(Figure 2E,F) and in changes similar to those observed upon
LNA 1 binding to the slippery sequence helix and LNA 3
binding to the alternate lower stem. SHAPE reactivities
decreased for nucleotides 1641−1643 and increased for
nucleotides 1590−1595, consistent with a transition from the
alternate lower stem to the conventional lower stem. These
results suggest that the anchoring helix stabilizes the alternate
lower stem.
Formation of the Conventional Lower Stem Destabilizes the Slippery Sequence Helix. Binding by LNAs 3, 5,

and 6 all induced a switch in RNA conformation from the
alternate lower stem to the conventional lower stem (Figure
2C,E,F, red boxes). Binding by these LNAs also resulted in
increased SHAPE reactivity at the slippery sequence helix
(Figure 2C,E,F, yellow boxes). Remarkably, these changes even
occurred upon disruption of the relatively distant anchoring
helix by LNAs 5 and 6. In contrast, LNA 4, which destabilized
the alternate lower stem but did not induce the formation of
the conventional lower stem, did not cause signiﬁcant SHAPE
reactivity changes in the slippery sequence helix (Figure 2D).
These results suggest that the alternate lower stem and slippery
sequence stabilize one another and are structurally coupled.
Frameshift Helix Stability Revealed by Formamide
Denaturation. We next examined the relative stabilities of the
four main helices present in the SHAPE-directed frameshift
element. Formamide denatures nucleic acid structure.33 Therefore, we incubated HIV-1 RNA in buﬀer containing a range
(0−60% vol/vol) of formamide concentrations with the
expectation that global reactivity to 1M7 would increase with
denaturant concentration. Following a 20 min incubation at 37
°C in folding buﬀer, we added formamide and incubated the
solution for a further 20 min before initiating SHAPE probing
with 1M7.
At 20% formamide, nucleotides involved in the slippery
sequence helix showed increased SHAPE reactivity relative to
the buﬀer without formamide (Figure 3A,B). Nucleotides
involved in the alternate lower stem exhibited reactivity changes

Figure 3. Secondary structure models for the frameshift domain RNA
as a function of formamide concentration.
4286
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Figure 4. Structure of in virio compared with ex virio RNA. (A) SHAPE reactivity proﬁles and (B) predicted secondary structure model.

that suggest a switch to the conventional lower stem at 20%
formamide (Figure 3B and Supporting Information, Figure 2).
In 40% formamide, SHAPE reactivities indicated that the
conventional lower stem was unfolded (Figure 3C). Nearest
neighbor thermodynamic calculations indicate that the conventional lower stem is slightly more stable than the SHAPEdirected alternate lower stem (−8.4 kcal/mol and −8.2 kcal/
mol, respectively). We hypothesize that the formation of the
alternate lower stem is largely dependent on stabilization from
other elements in the domain and that, when these interactions
are disrupted by LNA binding or by formamide denaturation,
the slightly more stable conventional lower stem is able to form.
The anchoring helix and upper stem show very low SHAPE
reactivities up to 40% formamide. Nucleotides in the anchoring
helix became reactive only at 60% formamide, and nucleotides
in the upper stem remained unreactive even at this high
denaturant concentration (Figure 3D). The high stability of the
upper stem was noted previously.34 We conclude from these
experiments that the frameshift domain is bounded by two
highly stable helices and that the intervening less stable helices
have the propensity to unfold upon perturbation and, in the
case of the lower stem, refold into alternative conformations.
Frameshift Domain Is Less Structured In Virio than in
Isolated RNA. We next probed the frameshift region of HIV-1
RNA as it exists packaged inside virions using the well-validated
1M7 SHAPE reagent. Structural interrogation of the in virio
state is possible because SHAPE reagents readily cross
biological membranes.35,36 SHAPE probing indicated that the
frameshift domain of RNA packaged within the virion adopted
a much less structured conformation than that adopted by
either gently deproteinized genomic (ex virio) or refolded RNA

(Figure 4). Nucleotides involved in the slippery sequence helix
and lower stem, including both the conventional and alternate
base-pairings, displayed higher SHAPE reactivities in virio than
in isolated RNA. These diﬀerences could reﬂect RNA refolding
or protein binding in the in virio environment. In contrast,
SHAPE reactivities for the anchoring helix and upper stem
remained low, suggesting that these elements folded stably
inside virions.
SHAPE-Predicted Alternate Lower Stem Is Required
for Native-Like Frameshifting. While the LNA binding
experiments conﬁrmed the existence of all helices unique to the
SHAPE-directed model, the formamide denaturation and in
virio experiments showed that some of these helices are
relatively unstable. To determine the biological importance of
each of these helices, we examined a set of mutants designed to
disrupt individual predicted helices and evaluated frameshifting
eﬃciency in a dual luciferase reporter assay.22 Using this
system, we were unable to detect any signiﬁcant eﬀect on
frameshifting upon disruption of either the anchoring helix
(Figure 5, mutants 1 and 2) or the conventional lower stem
(Figure 5, mutant 3). However, when the alternate lower stem
was disrupted, a signiﬁcant decrease in frameshifting was
observed (Figure 5, mutant 4). We conclude that native-like
frameshifting levels are dependent on the formation of the
alternate, but not necessarily the conventional, lower stem.
These results suggest that the alternate lower stem is a potential
therapeutic target.
A very diﬀerent result was obtained when the anchoring
helix, alternate lower stem, and slippery site helix were
simultaneously disrupted by mutagenesis (Figure 5, mutant
5). In this case, frameshifting increased to greater than native4287
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Frameshifting at an Alternate Slippery Sequence Is
Dependent on Downstream Structure. The alternate lower
stem overlaps with a UUUUCUU sequence (nucleotides
1676−1682) that resembles the conserved UUUUUUA
slippery sequence. In viruses resistant to protease inhibitors,
the C in this downstream region is frequently mutated to U.38
At the protein level, this causes a Leu to Phe mutation that may
increase cleavage eﬃciency and enhance the production of
functional protease. This site could also act as a secondary
slippery sequence that increases the overall amount of
frameshifting, thereby increasing the relative amount of
protease to compensate for reduction in protease activity in
the presence of inhibitor.39 When the standard slippery
sequence is inactivated by mutation, the mutant with the C
to U change in the alternate slippery site, but not that
containing the wild-type sequence, stimulates frameshifting in
in vitro translation assays. In cell culture, no frameshifting was
detected from the secondary site using HIV-1 sequences
shorter than the 140-nt domain described here.40 However, the
construct used could not form ﬂanking structures such as the
anchoring helix and the adjacent 3-bp helix predicted by
SHAPE-directed folding.
We therefore revisited frameshifting from this alternate
slippery sequence in the context of the complete frameshift
domain. We inactivated the standard slippery sequence by sitedirected mutagenesis (Figure 6, Δss); this reduced frameshifting eﬃciency by 5-fold in the luciferase reporter assay. The
reporter containing the C1680U mutation in the alternate
slippery sequence in this Δss background (Figure 6, mutant 6)
showed a 3-fold increase in frameshifting eﬃciency relative to
the Δss construct. We then disrupted the anchoring helix
(Figure 6, mutant 7) and the adjacent 3-bp helix (mutant 8) in
the Δss background. Disruption of the anchoring helix had no
eﬀect on frameshift eﬃciency, but disruption of the 3-nt helix
reduced frameshifting to levels similar to those of the Δss
construct. We conclude that the C1680U mutation creates a
second functional slippery sequence and that frameshifting
from the secondary site requires both a slippery sequence and a
downstream base-paired structure.

■

Figure 5. Frameshifting eﬃciencies on transcripts with mutations in
predicted helical regions. (A) Native and mutant sequences and (B)
relative frameshift eﬃciencies. Constructs were designed to disrupt the
anchoring helix (1 and 2), conventional lower stem (3), SHAPEdirected alternate lower stem (4), and both the anchoring helix and
alternate lower stem simultaneously (5). Mutated positions are shown
in red. For mutants 3 and 4, the entire anchoring helix is present, but
only 3 base pairs are shown. Frameshift eﬃciencies were normalized
by setting the measured native sequence value of 5.4 ± 0.9% equal to
1.0.

DISCUSSION
Here, we analyzed in detail the structure of the frameshift
domain in the context of full-length HIV-1 genomic RNA. Our
data provide support for the three main helices unique to the
frameshift domain model proposed based on SHAPE-directed
folding of an entire HIV-1 genome (Figure 1).15 Models for the
frameshift domain that contain pseudoknots have recently been
proposed;9 however, ex virio SHAPE data (Figure 1) and prior
frameshifting assays22 do not support a contribution of these
pseudoknots to the observed structural ensemble or frameshifting eﬃciency. Our model shares a stable upper stem with the
previously proposed two-helix model11 but has two important
diﬀerences. First, this study supports alternative pairing
partners for bases in the conventional lower stem. Second,
the SHAPE-directed model spans a 140-nt region that includes
the slippery sequence and an additional stable anchoring helix.
A key feature of the present study is the use of full-length
genomic RNA. Using a long RNA avoids the biases that are
often introduced when a truncated sequence of an RNA is
studied and ensures that important structural regions are not
omitted. Most past studies of the HIV-1 frameshift domain,
including NMR analyses that tested the two-helix model,12,13
used HIV-1 sequences that were much shorter than the 140-nt

like levels. These results agree with a prior report that
frameshifting eﬃciency of a construct containing only the
upper stem and conventional lower stem is approximately twice
that of a construct that contains the entire SHAPE-predicted
domain.22 Together, these data are consistent with a translational pausing mechanism whereby structured regions preceding the frameshift site regulate ribosome spacing.37 That these
results diﬀer from those obtained when the anchoring helix and
alternate lower stem were mutated independently supports our
hypotheses that there is strong structural coupling between
these elements and that these helices have overlapping
functional roles in modulating frameshifting eﬃciency.
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between the SHAPE-directed model and the conventional
model are due primarily to the presence of the complete
sequence of the viral RNA that was used in development of the
SHAPE-directed model. Co-transcriptional RNA folding thus
apparently does not alter the folding of this region of the
genome. However, inside virions, portions of the frameshift
domain are less structured than in the extracted RNA,
suggesting that higher-order protein or ligand interactions
modulate domain structure in the native virion environment.
The anchoring helix and upper stem are very stable and
persist even in the presence of high concentrations of
formamide (Figure 3). Furthermore, the in virio experiments
show that these two helices are the only frameshift domain
helices that form stably inside the virion. In the absence of
tertiary structure or other potentially stabilizing interactions,
the conventional lower stem is predicted to be slightly more
stable than the SHAPE-directed alternate lower stem, and in
20% formamide, we observed a switch from the alternative stem
to the conventional lower stem. These data suggest that the
structure of the frameshift region is dependent on the local
microenvironment.
The changes induced by LNA binding suggest that the
structure of the frameshift domain is dynamic as the ribosome
moves through this region. The anchoring helix is the ﬁrst
frameshift domain secondary structural element to be unwound
by the translating ribosome (Figure 7A,B). LNA binding
experiments indicate that unwinding of this helix induces a
major structural rearrangement throughout the frameshift
domain. The lower stem switches from the alternate helix to
the conventional stem conformation, and the slippery sequence
helix is signiﬁcantly destabilized. The functional implications of
this structural rearrangement are not understood, but the

Figure 6. Frameshifting eﬃciencies for analysis of the secondary
frameshift site. (A) Native and mutant sequences and (B) relative
frameshift eﬃciencies. Construct Δss has mutations that disrupt the
standard slippery sequence. All other constructs also contain the Δss
mutation. Construct 6 additionally includes a C-to-U mutation that
creates the proposed secondary slippery sequence. Constructs 7 and 8
contain this secondary slippery sequence and additional mutations that
disrupt either the anchoring helix (7) or the 3-nt helix (8). Frameshift
eﬃciencies were normalized as in Figure 5.

region that we show here, which constitutes the full frameshift
domain. The three main helices unique to the SHAPE-directed
model were thus unable to form in the truncated sequences
analyzed previously. Two of these helices, the alternate lower
stem and the helix that sequesters the slippery sequence, appear
to mutually stabilize each other because disruption of either of
these helices by LNA binding destabilized or induced refolding
of the other (Figure 2). Additionally, the anchoring helix likely
stabilizes both of these helices. The frameshift domain adopts
the same structure whether the genomic RNA is probed
directly after extraction from virions or is ﬁrst heat-denatured
and then refolded. This similarity suggests that the diﬀerences

Figure 7. Model for frameshift domain unwinding during translation.
A C-to-U mutation (red) observed in viruses with resistance to
protease inhibitors38 creates a potential secondary slippery sequence.
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its function is dependent on structural elements outside the
traditional frameshift domain but within the SHAPE-directed
model. This work illustrates the inﬂuence of global sequence
context on RNA structure and the ability of SHAPE probing to
reveal complex functional domains in large RNAs.

importance of conformational switching was recently demonstrated in ribosomal recoding in another retrovirus.41 Prior
studies using an RNA containing up to 90 nucleotides of the
HIV-1 frameshift domain sequence indicate that sequences in
the conventional lower stem are functionally important for
frameshifting in cultured cells but not in rabbit reticulocyte
lysate.11,14 Our mutagenesis studies similarly show that
disruption of the conventional lower stem does not yield
detectable changes in frameshift eﬃciency in reticulocyte lysate
(Figure 5, compare WT vs 3). Using a longer fragment of HIV1 RNA that spans the entire SHAPE-deﬁned domain (nts
1567−1711), we observed that disrupting the alternate lower
stem while allowing the conventional lower stem to form
resulted in dramatically reduced frameshifting (Figure 5,
mutant 4). In contrast, when both the anchoring helix and
the alternate lower stem were disrupted while preserving the
ability of the conventional lower stem to form, frameshifting
actually increased above native-like levels (Figure 5, mutant 5).
Thus, the frameshift domain structure is dynamic, and the
stabilities of the component helices are coupled.
After unwinding the anchoring helix, the ribosome continues
toward the slippery sequence and encounters the conventional
lower stem. LNA 2 binding data suggest that unwinding of the
conventional lower stem results in a switch back to the alternate
lower stem conformation (Figure 7C). The ribosome must
then unwind the very stable upper stem and switch reading
frames. The high stability of the anchoring helix suggests that
this structure may reform after the ribosome has translated
through it. If this is the case, the ribosome would encounter the
anchoring helix for a second time before exiting the frameshift
domain (Figure 7D). The adjacent 3-bp helix could also
potentially reform and would be able to serve as the frameshift
stimulatory stem in HIV-1 sequence variants that contain a
second slippery sequence.
Frameshifting eﬃciency assays performed in the present
study revealed that the secondary slippery site can indeed
promote frameshifting. Previous studies40 likely failed to detect
frameshifting from this secondary site because of the use of
truncated sequences that were unable to form downstream
structures necessary for frameshifting. Frameshift eﬃciency is
primarily dependent upon the local stability of the ﬁrst three
base pairs of the helix located approximately eight nucleotides
from the slippery site, which is the length of RNA required to
span the distance from the slippery site to the ribosomal mRNA
entrance channel.22 Consistent with this eight nucleotide
distance, our results indicate that frameshifting from the
second slippery site is dependent upon the integrity of the 3-bp
helix but not the anchoring stem, which would be too far away
from the second slippery site to induce frameshifting (Figure
6).
In sum, this study conﬁrmed key structural elements speciﬁc
to the HIV-1 frameshift region model developed using SHAPE
probing data as knowledge-based restraints18,19 to computational folding algorithms.15 The frameshift region has
signiﬁcant conformational ﬂexibility, and we hypothesize that
a switch occurs between the SHAPE-predicted helices and the
two helices in the conventional model as the ribosome unwinds
the frameshift element. From a functional perspective, the
alternate lower stem is important for native-like frameshift
levels in the context of the larger domain structure and
consequently represents a potential therapeutic target. We also
examined the sequence and structural requirements of a
previously identiﬁed secondary frameshift site and found that
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